SIMULATIONS PLUS INC (SLP) competitors & alternatives
Health Care · NASDAQ
SIMULATIONS PLUS INC (SLP)'s top competitors and alternatives — its most similar public companies — include Certara, Inc. (CERT), Veeva Systems (VEEV), FORTREA HOLDINGS INC (FTRE), Aldeyra Therapeutics, Inc. (ALDX), Agilent Technologies (A), Labcorp (LH), Thermo Fisher Scientific (TMO), Medpace (MEDP), LIGAND PHARMACEUTICALS INC (LGND), Revvity (RVTY), Tempus AI (TEM) and NUVECTIS PHARMA INC (NVCT). These are SIMULATIONS PLUS INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top SLP competitors & alternatives
-
Certara, Inc.CERTHealth Care
Certara utilizes proprietary biosimulation software and expert-led AI to help pharmaceutical companies optimize drug development and increase the probability…
$6.89 (as of 2026-07-22) · market cap $1.1B
-
Veeva SystemsVEEVHealth Care
Veeva is the dominant cloud software and data platform powering the global life sciences industry from drug development through commercialization, with…
$184.55 (as of 2026-07-22) · market cap $29.8B
-
FORTREA HOLDINGS INCFTREHealth Care
Fortrea is a global contract research organization that accelerates the delivery of life-changing treatments by providing flexible, science-driven clinical…
$18.49 (as of 2026-07-22) · market cap $1.7B
-
Aldeyra Therapeutics, Inc.ALDXHealth Care
Aldeyra is a clinical-stage biotech pursuing FDA approval of reproxalap, an aldehyde dehydrogenase activator for ophthalmologic inflammation, dependent on…
$1.70 (as of 2026-07-22) · market cap $106M
-
Agilent TechnologiesAHealth Care
A diversified healthcare and life sciences company providing analytical instruments, software, and services for pharmaceutical, chemical, and clinical…
$133.46 (as of 2026-07-22) · market cap $37.6B
-
LabcorpLHHealth Care
A global diagnostics and drug development laboratory leader that performs 750+ million clinical tests annually and supports 85% of new FDA-approved drugs…
$281.46 (as of 2026-07-22) · market cap $23.1B
-
Thermo Fisher ScientificTMOHealth Care
Thermo Fisher Scientific is a leading global provider of mission-critical laboratory equipment, analytical instrumentation, and scientific services for…
$526.46 (as of 2026-07-22) · market cap $194.1B
-
MedpaceMEDPHealth Care
Medpace is a specialized, full-service clinical contract research organization that helps biopharmaceutical and medical device companies accelerate the…
$528.12 (as of 2026-07-22) · market cap $15.0B
-
LIGAND PHARMACEUTICALS INCLGNDHealth Care
Ligand Pharmaceuticals is a biotechnology firm that generates recurring revenue through royalty interests and the licensing of proprietary drug formulation…
$304.26 (as of 2026-07-22) · market cap $6.1B
-
RevvityRVTYHealth Care
Revvity is a leading health science technology company providing integrated workflows and reagents spanning drug discovery, development, and diagnostic…
$110.54 (as of 2026-07-22) · market cap $12.3B
-
Tempus AITEMHealth Care
Tempus AI leverages genomic sequencing, clinical data aggregation, and machine learning to deliver precision oncology diagnostics and AI-powered treatment…
$46.96 (as of 2026-07-22) · market cap $8.4B
-
NUVECTIS PHARMA INCNVCTHealth Care
Nuvectis is an early-stage oncology biotech developing NXP900, a novel SRC/YES1 kinase inhibitor designed to overcome drug resistance in solid tumors including…
$19.29 (as of 2026-07-22) · market cap $608M
Not quite? Describe exactly what you want →
Peers are SIMULATIONS PLUS INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: SIMULATIONS PLUS INC (SLP).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.